Related Experiment Video
Updated: Jul 2, 2025
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
Annika Kasprzak1, Julia Andresen1, Kathrin Nachtkamp1
1Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, 40225 Duesseldorf, Germany.
Abstract:
Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying therapies are particularly vulnerable to developing infectious complications, increasing the risk of mortality. Myelodysplastic syndromes (MDS) predominantly affect the elderly, with the incidence rising with age and peaking at around 70 years. Patients with MDS commonly present with unexplained low blood-cell counts, primarily anemia, and often experience varying degrees of neutropenia as the disease progresses. In our subsequent retrospective study involving 1593 patients from the Düsseldorf MDS Registry, we aimed at outlining the incidence of infections in MDS patients and identifying factors contributing to heightened susceptibility to infectious complications in this population.
Insights
Patients with myelodysplastic syndromes (MDS) face high risks of infections, especially during treatments like chemotherapy. This study identifies key factors contributing to infection susceptibility in elderly MDS patients.
Area of Science:
- Hematology
- Oncology
- Infectious Diseases
Background:
- Hematologic malignancies pose significant risks for infectious complications.
- Chemotherapy and disease-modifying therapies increase patient vulnerability to infections and mortality.
- Myelodysplastic syndromes (MDS) predominantly affect the elderly, often presenting with anemia and neutropenia.
Purpose of the Study:
- To determine the incidence of infections in patients with myelodysplastic syndromes.
- To identify factors associated with increased susceptibility to infectious complications in MDS patients.
Main Methods:
- Retrospective study.
- Analysis of 1593 patients from the Düsseldorf MDS Registry.
Main Results:
- The study outlines the incidence of infections in MDS patients.
- Factors contributing to heightened susceptibility to infectious complications were identified.
Conclusions:
- Infections remain a critical concern for patients with myelodysplastic syndromes.
- Understanding risk factors is crucial for improving infection prevention and management in this population.
